Entry |
|
Symbol |
Mapk1, 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1, p41mapk, p42mapk
|
Name |
(RefSeq) mitogen-activated protein kinase 1
|
KO |
|
Organism |
mmu Mus musculus (house mouse)
|
Pathway |
mmu01521 | EGFR tyrosine kinase inhibitor resistance |
mmu04072 | Phospholipase D signaling pathway |
mmu04261 | Adrenergic signaling in cardiomyocytes |
mmu04270 | Vascular smooth muscle contraction |
mmu04550 | Signaling pathways regulating pluripotency of stem cells |
mmu04613 | Neutrophil extracellular trap formation |
mmu04620 | Toll-like receptor signaling pathway |
mmu04621 | NOD-like receptor signaling pathway |
mmu04625 | C-type lectin receptor signaling pathway |
mmu04650 | Natural killer cell mediated cytotoxicity |
mmu04658 | Th1 and Th2 cell differentiation |
mmu04660 | T cell receptor signaling pathway |
mmu04662 | B cell receptor signaling pathway |
mmu04664 | Fc epsilon RI signaling pathway |
mmu04666 | Fc gamma R-mediated phagocytosis |
mmu04723 | Retrograde endocannabinoid signaling |
mmu04810 | Regulation of actin cytoskeleton |
mmu04914 | Progesterone-mediated oocyte maturation |
mmu04919 | Thyroid hormone signaling pathway |
mmu04928 | Parathyroid hormone synthesis, secretion and action |
mmu04933 | AGE-RAGE signaling pathway in diabetic complications |
mmu04935 | Growth hormone synthesis, secretion and action |
mmu04960 | Aldosterone-regulated sodium reabsorption |
mmu05022 | Pathways of neurodegeneration - multiple diseases |
mmu05163 | Human cytomegalovirus infection |
mmu05166 | Human T-cell leukemia virus 1 infection |
mmu05167 | Kaposi sarcoma-associated herpesvirus infection |
mmu05170 | Human immunodeficiency virus 1 infection |
mmu05207 | Chemical carcinogenesis - receptor activation |
mmu05208 | Chemical carcinogenesis - reactive oxygen species |
mmu05230 | Central carbon metabolism in cancer |
mmu05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:mmu00001]
09130 Environmental Information Processing
09132 Signal transduction
04014 Ras signaling pathway
26413 (Mapk1)
04015 Rap1 signaling pathway
26413 (Mapk1)
04350 TGF-beta signaling pathway
26413 (Mapk1)
04668 TNF signaling pathway
26413 (Mapk1)
04066 HIF-1 signaling pathway
26413 (Mapk1)
04068 FoxO signaling pathway
26413 (Mapk1)
04072 Phospholipase D signaling pathway
26413 (Mapk1)
04071 Sphingolipid signaling pathway
26413 (Mapk1)
04024 cAMP signaling pathway
26413 (Mapk1)
04022 cGMP-PKG signaling pathway
26413 (Mapk1)
04151 PI3K-Akt signaling pathway
26413 (Mapk1)
04150 mTOR signaling pathway
26413 (Mapk1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
26413 (Mapk1)
04148 Efferocytosis
26413 (Mapk1)
09144 Cellular community - eukaryotes
04550 Signaling pathways regulating pluripotency of stem cells
26413 (Mapk1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
26413 (Mapk1)
04613 Neutrophil extracellular trap formation
26413 (Mapk1)
04620 Toll-like receptor signaling pathway
26413 (Mapk1)
04650 Natural killer cell mediated cytotoxicity
26413 (Mapk1)
04660 T cell receptor signaling pathway
26413 (Mapk1)
04658 Th1 and Th2 cell differentiation
26413 (Mapk1)
04659 Th17 cell differentiation
26413 (Mapk1)
04657 IL-17 signaling pathway
26413 (Mapk1)
04662 B cell receptor signaling pathway
26413 (Mapk1)
04664 Fc epsilon RI signaling pathway
26413 (Mapk1)
04666 Fc gamma R-mediated phagocytosis
26413 (Mapk1)
04062 Chemokine signaling pathway
26413 (Mapk1)
09152 Endocrine system
04929 GnRH secretion
26413 (Mapk1)
04915 Estrogen signaling pathway
26413 (Mapk1)
04917 Prolactin signaling pathway
26413 (Mapk1)
04921 Oxytocin signaling pathway
26413 (Mapk1)
04926 Relaxin signaling pathway
26413 (Mapk1)
04935 Growth hormone synthesis, secretion and action
26413 (Mapk1)
04919 Thyroid hormone signaling pathway
26413 (Mapk1)
04928 Parathyroid hormone synthesis, secretion and action
26413 (Mapk1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
26413 (Mapk1)
09156 Nervous system
04724 Glutamatergic synapse
26413 (Mapk1)
04725 Cholinergic synapse
26413 (Mapk1)
04726 Serotonergic synapse
26413 (Mapk1)
04720 Long-term potentiation
26413 (Mapk1)
04730 Long-term depression
26413 (Mapk1)
04723 Retrograde endocannabinoid signaling
26413 (Mapk1)
04722 Neurotrophin signaling pathway
26413 (Mapk1)
09158 Development and regeneration
04360 Axon guidance
26413 (Mapk1)
04380 Osteoclast differentiation
26413 (Mapk1)
09159 Environmental adaptation
04713 Circadian entrainment
26413 (Mapk1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
26413 (Mapk1)
05206 MicroRNAs in cancer
26413 (Mapk1)
05205 Proteoglycans in cancer
26413 (Mapk1)
05207 Chemical carcinogenesis - receptor activation
26413 (Mapk1)
05208 Chemical carcinogenesis - reactive oxygen species
26413 (Mapk1)
05203 Viral carcinogenesis
26413 (Mapk1)
05230 Central carbon metabolism in cancer
26413 (Mapk1)
05231 Choline metabolism in cancer
26413 (Mapk1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
26413 (Mapk1)
09162 Cancer: specific types
05210 Colorectal cancer
26413 (Mapk1)
05212 Pancreatic cancer
26413 (Mapk1)
05225 Hepatocellular carcinoma
26413 (Mapk1)
05226 Gastric cancer
26413 (Mapk1)
05214 Glioma
26413 (Mapk1)
05216 Thyroid cancer
26413 (Mapk1)
05221 Acute myeloid leukemia
26413 (Mapk1)
05220 Chronic myeloid leukemia
26413 (Mapk1)
05218 Melanoma
26413 (Mapk1)
05211 Renal cell carcinoma
26413 (Mapk1)
05219 Bladder cancer
26413 (Mapk1)
05215 Prostate cancer
26413 (Mapk1)
05213 Endometrial cancer
26413 (Mapk1)
05224 Breast cancer
26413 (Mapk1)
05223 Non-small cell lung cancer
26413 (Mapk1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
26413 (Mapk1)
05170 Human immunodeficiency virus 1 infection
26413 (Mapk1)
05161 Hepatitis B
26413 (Mapk1)
05160 Hepatitis C
26413 (Mapk1)
05171 Coronavirus disease - COVID-19
26413 (Mapk1)
05164 Influenza A
26413 (Mapk1)
05163 Human cytomegalovirus infection
26413 (Mapk1)
05167 Kaposi sarcoma-associated herpesvirus infection
26413 (Mapk1)
05165 Human papillomavirus infection
26413 (Mapk1)
09171 Infectious disease: bacterial
05135 Yersinia infection
26413 (Mapk1)
05133 Pertussis
26413 (Mapk1)
05152 Tuberculosis
26413 (Mapk1)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
26413 (Mapk1)
05140 Leishmaniasis
26413 (Mapk1)
05142 Chagas disease
26413 (Mapk1)
09164 Neurodegenerative disease
05010 Alzheimer disease
26413 (Mapk1)
05020 Prion disease
26413 (Mapk1)
05022 Pathways of neurodegeneration - multiple diseases
26413 (Mapk1)
09165 Substance dependence
05034 Alcoholism
26413 (Mapk1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
26413 (Mapk1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
26413 (Mapk1)
04933 AGE-RAGE signaling pathway in diabetic complications
26413 (Mapk1)
04934 Cushing syndrome
26413 (Mapk1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
26413 (Mapk1)
01524 Platinum drug resistance
26413 (Mapk1)
01522 Endocrine resistance
26413 (Mapk1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mmu01001]
26413 (Mapk1)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:mmu03036]
26413 (Mapk1)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:mmu04147]
26413 (Mapk1)
Enzymes [BR:mmu01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
26413 (Mapk1)
Protein kinases [BR:mmu01001]
Serine/threonine kinases: CMGC group
MAPK family [OT]
26413 (Mapk1)
Chromosome and associated proteins [BR:mmu03036]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
26413 (Mapk1)
Exosome [BR:mmu04147]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
26413 (Mapk1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
16:16801246..16865317
|
AA seq |
358 aa
MAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ
TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS
NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG
FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG
ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI
EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS |
NT seq |
1077 nt +upstreamnt +downstreamnt
atggcggcggcggcggcggcgggcccggagatggtccgcgggcaggtgttcgacgtaggg
ccgcgctacaccaacctctcgtacatcggagaaggcgcctacggcatggtttgctctgct
tatgataatctcaacaaagttcgagttgctatcaagaaaatcagtccttttgagcaccag
acctactgtcaaagaaccctaagagagataaaaatcttactgcgcttcagacatgagaac
atcattggcatcaatgacatcatccgggcaccaaccattgagcaaatgaaagatgtatat
atagtacaggacctcatggagacggacctttacaagctcttgaagacacagcacctcagc
aatgaccacatctgctattttctttatcagatcctgagagggctaaagtatatccattca
gctaacgttctgcaccgtgacctcaagccttccaacctcctgctgaacaccacttgtgat
ctcaagatctgtgactttggccttgcccgtgttgcagatccagatcatgatcacacaggg
ttcttgacagagtacgtagccacacgttggtacagagctccagaaattatgttgaattcc
aagggttataccaagtccattgatatttggtctgtgggctgcatcctggcagagatgcta
tccaacaggcctatcttcccaggaaagcattaccttgaccagctgaatcacatcctgggt
attcttggatctccatcacaggaagatctgaattgtataataaatttaaaagctagaaac
tatttgctttctctcccgcacaaaaataaggtgccatggaacaggttgttcccaaatgct
gactccaaagctctggatttactggataaaatgttgacatttaaccctcacaagaggatt
gaagttgaacaggctctggcccacccatacctggagcagtattatgacccaagtgatgag
cccattgctgaagcgccattcaagtttgacatggagttggacgacttacctaaggagaag
ctcaaagaactcatttttgaagagactgctagattccagccaggatacagatcttaa |